May8 | Sanofi India Limited - Change in Director(s) Sanofi India Limited has
informed the Exchange that the Board of Directors of the Company at its
meeting held on April 30, 2013, has appointed Ms. Joanna Potts as Alternate
to Mr. A. Ortoli with effect from May 01, 2013 |
May6 | Sanofi India Limited - Updates Sanofi India Limited has submitted to the Exchange a copy of the Speech of the Chairman, Dr. Vijay Mallya
delivered at the Annual General Meeting held on April 30, 2013. |
Mar5 | Sanofi India Limited - Book Closure Sanofi India Limited has
informed the Exchange that the Register of Members and Share Transfer Books
of the Company will be closed from April 09, 2013 to April 30, 2013 (both
days inclusive) for the purpose of [1] Annual General Meeting to be held on
April 30, 2013; and [2] Payment of Final Dividend of Rs. 29 per Equity
share of Rs. 10 for the financial year ended December 31, 2012, recommended
by the Board of Directors, if declared at the Annual General Meeting to be
held on April 30, 2013. |
Feb26 | Sanofi India Limited - Dividend Sanofi India Limited has informed
the Exchange that the Board of Directors of the Company at its meeting held
on February 25, 2013, the Board has recommended Final dividend of Rs. 29
per Equity share of Rs. 10 for the year ended December 31, 2012. |
Feb15 | Sanofi India Limited - Press Release Sanofi India Limited has
informed the Exchange regarding a press release dated February 14, 2013,
titled "Sanofi India launches Combiflam Plus- A targeted, fast and
effective OTC solution for headaches". |
Jan14 | Sanofi India Limited - Disclosure under Insider Trading Regulation Aberdeen Asset Management Limited has submitted to the Exchange
vide its letter dated January 09, 2013 a copy of Disclosure under
Regulation 13(3) and 13(6) of SEBI (Prohibition of Insider Trading)
Regulations, 1992. |
Jan11 | Sanofi India Limited - Disclosure under SEBI Takeover Regulations Sanofi India Limited has submitted to the Exchange vide its
letter dated January 10, 2013 a copy of disclosure under Regulation 29(2)
of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011
along with Disclosure under Regulation 13(3) and 13(6) of SEBI (Prohibition
of Insider Trading) Regulations, 1992. |
Oct9 | Sanofi India Limited - Press Release Sanofi India Limited has
informed the Exchange regarding a press release dated October 09, 2012,
titled "Sanofi launches specially designed `made in India` re-usable
insulin pen - AllStar". |
Jul26 | Sanofi India Limited - Interim Dividend Sanofi India Limited has
informed the Exchange that the Board of Directors of the Company at its
meeting held on July 25, 2012, declared an Interim Dividend of Rs. 4
(Rupees Four Only) per Equity Share of Rs.10 for the financial year ending
December 31, 2012. The Interim Dividend will be paid on August 16, 2012. |
Jul23 | Sanofi India Limited - Record Date Sanofi India Limited has
informed the Exchange that in case Interim Dividend is declared by the
Board at the Board meeting to be held on July 25, 2012, the Record date for
the purpose of payment of such Interim Dividend will be August 03, 2012. |
Jul6 | Aventis Pharma Limited - Change in Company Name / Symbol Members of the Exchange are hereby informed that the name of Aventis Pharma
Limited shall be changed to Sanofi India Limited and the trading symbol of
the Company be changed from AVENTIS to SANOFI w.e.f. July 11, 2012. |
Jun28 | Aventis Pharma Limited - Resignation of Director Aventis Pharma Limited has informed the Exchange that Mr. M. Dargentolle has
resigned as Chief Financial Officer and Wholetime Director of the Company
with effect from the close of business hours from June 30, 2012 as he is
taking up a position in the R & D Division of the Sanofi Group in France. |
May17 | Aventis Pharma Limited - Minutes of Annual General Meeting Aventis Pharma Limited has submitted to the Exchange a copy of the Minutes
of the proceedings of the Annual General Meeting of the Members of the
Company held on May 03, 2012. |
May16 | Aventis Pharma Limited - Company Name Change Aventis Pharma Limited has
informed the Exchange that the name of the Company has been
changed from `AVENTIS PHARMA LIMITED` to `SANOFI INDIA LIMITED` with effect
from May 11, 2012. A Fresh Certificate of incorporation consequent upon
Change of Name of the Company issued by the Registrar of Companies,
Maharashtra. |
May11 | Aventis Pharma Limited - Change in Director(s) Aventis Pharma Limited has
informed the Exchange that at its Meeting held on May 3, 2012,
the Board of Directors has appointed Mr. S. Umesh as Alternate to Mr.
Ortoli with effect from May 4, 2012. |
May8 | Aventis Pharma Limited - Disclosure of Voting Pattern - Clause 35A Aventis Pharma Limited has submitted to the Exchange a copy of
the details of the voting results at the Annual General Meeting of the
Company held on May 03, 2012. |
May7 | Aventis Pharma Limited - Updates Aventis Pharma Limited has
submitted to the Exchange a copy of the Speech of the Chairman, Dr. Vijay
Mallya delivered at the Annual General Meeting held on May 03, 2012. |
Mar13 | Aventis Pharma Limited - AGM / Book Closure Aventis Pharma Limited has
informed the Exchange that the Register of Members and Share
Transfer Books of the Company will be closed from April 12, 2012 to May 03,
2012 (both days inclusive) for the following purposes: [1] Annual General
Meeting to be held on May 03, 2012. [2] Payment of Final Dividend of Rs. 29
per Equity share of Rs. 10 for the year ended December 31, 2011,
recommended by the Board of Directors, if declared at the Annual General
Meeting to be held on May 03,2012. |
Nov4 | Aventis Pharma Limited - Updates Aventis Pharma Limited has
informed the Exchange vide its letter dated November 03, 2011, regarding
"Acquisition of Nutraceutical business of Universal Medicare Private
Limited". |
Sep2 | Aventis Pharma Limited - Change in Director(s) Aventis Pharma Limited has
informed the Exchange that Mr. O. Charmeil and Mr. F. X.
Duhalde have resigned as Directors of the Company with effect from August
23, 2011. The Board of Directors has appointed Mr. A. Ortoli (Senior Vice
President - Intercontinental of the Sanofi Group) and Mr. F. Briens (Vice
President - Finance, Intercontinental of the Sanofi Group) as Directors of
the Company in the casual vacancies caused by the resignations of Mr.
Charmeil and Mr. Duhalde, respectively. |
Aug24 | Aventis Pharma Limited - Press Release Aventis Pharma Limited has
informed the Exchange regarding a press release dated August 24, 2011,
titled "Aventis Pharma Limited to acquire Universal Medicare`s
Nutraceutical business in india". |
Jul28 | Aventis Pharma Limited - Interim Dividend Aventis Pharma Limited has
informed the Exchange that the Board of Directors of the
Company at its meeting held on July 28, 2011, declared an Interim Dividend
of Rs. 4 (Rupees Four Only) per Equity Share of Rs.10 for the financial
year ending December 31, 2011. |
Jul21 | Aventis Pharma Limited - Record Date Aventis Pharma Limited has
informed the Exchange that in case Interim Dividend is declared by the
Board at the Board meeting to be held on July 28, 2011, the Record date for
the purpose of payment of such Interim dividend will be August 04, 2011. |
May17 | Aventis Pharma Limited - Minutes of Annual General Meeting Aventis Pharma Limited has submitted to the Exchange a copy of the minutes
of the Annual General Meeting of the Members of the Company held on April
26, 2011. |
May3 | Aventis Pharma Limited - Updates Aventis Pharma Limited has
submitted to the Exchange a copy of the speech of the Chairman, Dr Vijay
Mallya delivered at the Annual General Meeting held on April 26, 2011. |
Apr11 | Aventis Pharma Limited - Resignation of Director Aventis Pharma Limited has
informed the Exchange that Mr. S. C. Ghoge has resigned
as Alternate Director to Mr. F.X. Duhalde and Wholetime Director with
effect from the close of business hours on March 31, 2011 as he has taken
premature retirement from the services of the Company. |
Apr6 | Aventis Pharma Limited - Annual General Meeting Aventis Pharma Limited has submitted to the Exchange a copy of notice of Annual General Meeting to be held on April 26, 2011. |
Feb17 | Aventis Pharma Limited - Dividend Aventis Pharma Limited has
informed the Exchange that the Board of Directors of the Company at its
meeting held on February 16, 2011, inter alia, has recommended: (1) Final
Dividend of Rs. 23 per Equity share of Rs. 10 for the year ended December
31, 2010. An Interim dividend of Rs. 4 per Equity share of Rs. 10 had been
paid in August 2010. (2) A Special One-time Dividend of Rs. 28 per Equity
share of Rs. 10 arising from the profit of the sale of the Company`s
shareholding in Chiron Behring Vaccines Private Limited. |
Dec28 | Aventis Pharma Limited - Updates Aventis Pharma Limited has informed the Exchange vide its letter dated December 27, 2010, regarding "Sale of 49% shareholding in Chiron Behring Vaccines Private Limited". |
Dec14 | Aventis Pharma Limited - Updates Aventis Pharma Limited has
informed the Exchange vide its letter dated December 13, 2010, regarding
"Sale of 49% shareholding in Chiron Behring Vaccines Private Limited". |
Dec1 | Aventis Pharma Limited - Press Release Aventis Pharma Limited has
informed the Exchange regarding a press release dated November 29,
2010, titled "Sanofi-aventis launches `I Am A Champ` program to celebrate
diabetes control". |
Nov23 | Aventis Pharma Limited - Updates Aventis Pharma Limited has
submitted to the Exchange a copy of notice sent to shareholders regarding
appointment of and remuneration payable to Mr. M.G. Rao as Wholetime
Director (Alternate to Mr. J. M. Georges) for the period from October 25,
2010 to September 05, 2011. |
Nov8 | Aventis Pharma Limited - Change in Director(s) Aventis Pharma Limited has
informed the Exchange that at its Meeting held on October 25,
2010, the Board of Directors has appointed Mr. M. G. Rao and Mr. S.C Ghoge
as Alternates to Mr. J. M. Georges and Mr. F. X. Duhalde. |
Sep9 | Aventis Pharma Limited - Change in Director(s) A v e n t i s P h a r m a L i m i t e d h a s
i n f o r m e d t h e E x c h a n g e t h a t t h e f o l l o w i n g c h a n g e s h a v e t a k e n
p l a c e i n t h e B o a r d o f D i r e c t o r s o f t h e C o m p a n y : ( 1 ) M r . M . D a r g e n t o l l e ,
C h i e f F i n a n c i a l O f f i c e r o f t h e C o m p a n y w h o w a s A l t e r n a t e D i r e c t o r t o M r . O .
C h a r m e i l h a s b e e n a p p o i n t e d a D i r e c t o r o f t h e C o m p a n y w i t h e f f e c t f r o m J u l y
1 9 , 2 0 1 0 ; ( 2 ) M r . J . M . G e o r g e s , D i r e c t o r , I n d u s t r i a l P h a r m a
I n t e r c o n t i n e n t a l o f t h e s a n o f i - a v e n t i s G r o u p a n d M r . F . X . D u h a l d e ,
D i r e c t o r - F i n a n c e & A d m i n i s t r a t i o n o f t h e s a n o f i - a v e n t i s G r o u p , h a v e b e e n
a p p o i n t e d a s A d d i t i o n a l D i r e c t o r s o f t h e C o m p a n y w i t h e f f e c t f r o m J u l y 2 9 ,
2 0 1 0 . |
Sep1 | Aventis Pharma Limited - Reappointment A v e n t i s P h a r m a L i m i t e d h a s
s u b m i t t e d t o t h e E x c h a n g e a c o p y o f N o t i c e s e n t t o S h a r e h o l d e r s
r e g a r d i n g r e - a p p o i n t m e n t o f D r . S . A y y a n g a r a s M a n a g i n g D i r e c t o r o f t h e
C o m p a n y . |
Jul20 | Aventis Pharma Limited - Dividend A v e n t i s P h a r m a L i m i t e d h a s
i n f o r m e d t h e E x c h a n g e t h a t t h e B o a r d o f D i r e c t o r s o f t h e C o m p a n y a t i t s
m e e t i n g h e l d o n J u l y 1 9 , 2 0 1 0 , d e c l a r e d a n I n t e r i m D i v i d e n d o f R s . 4 p e r
E q u i t y s h a r e o f R s . 1 0 t o b e p a i d t o t h o s e M e m b e r s w h o s e n a m e s a p p e a r o n
t h e R e g i s t e r o f M e m b e r s o f t h e C o m p a n y o n J u l y 2 7 , 2 0 1 0 , b e i n g t h e R e c o r d
D a t e . |
Jul14 | Aventis Pharma Limited - Record Date A v e n t i s P h a r m a L i m i t e d h a s
i n f o r m e d t h e E x c h a n g e t h a t i n c a s e I n t e r i m D i v i d e n d i s d e c l a r e d b y t h e
B o a r d a t t h e B o a r d m e e t i n g t o b e h e l d o n J u l y 1 9 , 2 0 1 0 , t h e R e c o r d d a t e f o r
t h e p u r p o s e o f p a y m e n t o f s u c h I n t e r i m d i v i d e n d w i l l b e J u l y 2 7 , 2 0 1 0 . |
Jun3 | Aventis Pharma Limited - Minutes of Annual General Meeting A v e n t i s P h a r m a L i m i t e d h a s s u b m i t t e d t o t h e E x c h a n g e a c o p y o f t h e M i n u t e s
o f t h e p r o c e e d i n g s o f t h e A n n u a l G e n e r a l M e e t i n g o f t h e C o m p a n y h e l d o n
A p r i l 2 7 , 2 0 1 0 . |